APA Citatie

Perumal, J., Balabanov, R., Su, R., Chang, R., Balcer, L., Galetta, S., . . . Fox, R. J. (2021). Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study. Adv Ther.

Chicago Style citaat

Perumal, Jai, et al. "Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study." Adv Ther 2021.

MLA citatie

Perumal, Jai, et al. "Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study." Adv Ther 2021.